http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Sasang Constitution Analysis and Wine Recommendation App suggestion through Mobile Face Recognition
Sung, Ki-hyuk,Ryu, Gi-hwan,Yun, Dai-yeol The Institute of Internet 2021 International Journal of Internet, Broadcasting an Vol.13 No.3
With the global COVID-19 pandemic, the tourism sector and all consumption have contracted with the untact era. Wine will also be sold and developed in various ways non-face-to-face in the future. Therefore, it is necessary to develop apps and web servers that focus on health in the era of single-person households and non-face-to-face. This study used facial recognition data based on photos of adult men and women in their 40s and 50s to analyze the Sasang constitution through a mobile app and web server, and suggested wine recommendations suitable for their constitution. First, the user's body information is entered. And through the facial recognition mobile app, recommend the right wine after analyzing the body type. if it's not like the first recommended wine, it is configured to receive another wine recommendation. In the future, the number of single-person households will increase further, and in the age of well-being, wine recommendations that fit my body will be useful. Wine recommendation suitable for Sasang constitution will be a useful mobile application to manage personal healt
Yun-Hee Choi,Yeon-Je Cho,Byung-Loc Kim,Min-Hee Han,Hak-Sung Lee,Yong-Gi Jeong 한국피부과학연구원 2021 아시안뷰티화장품학술지 Vol.19 No.1
목적: 본 연구는 전남 특산자원인 황칠, 천일염, 시금치 및 다시마 등으로부터 탈모증상 완화에 도움을 줄 수 있는 기능성 화장품 개 발을 위해 소재의 안전성 및 유효성을 입증하고자 수행되었다. 방법: 안전성 시험은 황칠과 천일염 등으로부터 중금속 및 세포 독성 에 대하여 확인하였고, 유효성은 항균 활성, 세포 증식율 및 항염증에 대하여 수행하였다. 결과: 중금속은 황칠, 천일염, 시금치 및 다시마 추출물에 대해 식품의약품안전처에서 제시한 안전성 기준치보다 낮거나 극미량 수준인 것으로 확인되었다. 세포 독성은 각 추출물에 대하여 황칠 0.01 mg/mL, 천일염 5 mg/mL, 시금치 0.5 mg/mL 및 다시마 0.5 mg/mL 농도 이내에서 안전한 것으로 확 인되었다. 항균 활성은 황칠 추출물에서만 확인되었고, 특히 열수 추출물에서 가장 높은 효과가 있었다. 세포 증식율은 열수 추출물 에 대하여 황칠 0.5 mg/mL, 시금치 5 mg/mL 및 다시마 2 mg/mL까지 증가하였다. 항염증은 다시마 열수 추출물을 제외한 모든 추출물에서 NO 생성량이 감소함에 따라 항염증 효과를 확인할 수 있었다. 특히 시금치 열수, 30% 주정 및 60% 주정 추출물과 다시 마의 60% 주정 추출물의 경우 50-500 μg/mL 범위에서 농도 의존적으로 NO 생성량이 감소하는 경향을 나타내었다. 결론: 본 연구 에서 황칠, 천일염, 시금치 및 다시마는 화장품 소재로써 안전하고, 효과적인 것으로 확인되었다. 따라서, 추가적인 연구를 수행하 여 황칠, 천일염, 시금치 및 다시마를 포함한 최적의 표준화를 통해 탈모 증상 완화에 도움을 주는 기능성 화장품으로서 활용되어질 것으로 기대된다. Purpose: Here, we evaluated the safety and effectiveness of Jeonnam’s unique resources, such as Dendropanax , sea salt, spinach, and kelp, to develop functional cosmetics that may alleviate hair loss. Methods: We performed safety tests with these resources, testing for heavy metals and cytotoxicity, and we evaluated their effectiveness as anti-microbial, cell proliferation, and anti-inflammation products. Results: The heavy metals concentration was lower than or in trace levels, as recommended by the Ministry of Food and Drug Safety’s standard of extracts such as Dendropanax , sea salt, etc. We confirmed cytotoxicity to be safe. In each extract, the concentrations of Dendropanax , sea salt, spinach, and kelp were 0.01 mg/mL, 5 mg/mL, 0.5 mg/mL, 0.5 mg/mL, respectively. Only the Dendropanax extract had microbial effect, with the distilled water extract reaching the highest effect. The cell proliferation increased to 0.5 mg/mL, 5 mg/mL, and 2 mg/mL for Dendropanax , spinach, and kelp with distilled water extract, the anti-inflammation effect increased. Conclusion: We found that Dendropanax , sea salt, spinach, and kelp were safe and effective as functional cosmetic materials to alleviate hair loss symptoms through optimal standardization. We suggest further research to evaluate these cosmetics’ functional effects.
Sung-Jin Choi,Jin-Woo Han,Moon-Gyu Jang,Jin Soo Kim,Kwang Hee Kim,Gi Sung Lee,Jae Sub Oh,Myeong Ho Song,Yun Chang Park,Jeoung Woo Kim,Yang-Kyu Choi IEEE 2009 IEEE electron device letters Vol.30 No.3
<P>A dopant-segregated Schottky barrier (DSSB) FinFET silicon-oxide-nitride-oxide-silicon (SONOS) for nor-type flash memory is successfully demonstrated. Compared with a conventional FinFET SONOS device, the DSSB FinFET SONOS device exhibits high-speed programming at low voltage. The sharp dopant-segregated Schottky contact at the source side can generate hot electrons, and it can be used to provide high injection efficiency at low voltage without any constraint on the choice of the proper gate and drain voltage. The DSSB FinFET SONOS device is therefore a promising candidate for nor-type flash memory with high-speed and low-power programming.</P>
The Urate-lowering Efficacy and Safety of Febuxostat in Korean Patients with Gout
( Sung Hwan Park ),( Yeong Wook Song ),( Won Park ),( Eun Mi Koh ),( Bin Yoo ),( Soo Kon Lee ),( Dae Hyun Yoo ),( Yun Jong Lee ),( Hyun Ah Kim ),( Hyo Jin Choi ),( Ho Youn Kim ),( Hyong Gi Jung ) 대한류마티스학회 2013 대한류마티스학회지 Vol.20 No.4
Objective. To compare the urate-lowering efficacy and the safety of febuxostat, allopurinol and placebo in Korean patients with gout for 4 weeks. Methods. Subjects (n=182) with gout were randomized to febuxostat (40, 80, 120 mg), allopurinol 300 mg, or placebo group. The primary end point was the proportion of subjects whose serum urate concentration fell to less than 6.0 mg/dL after the 4-week treatment. Results. The primary end point was reached at 25.7%, 80.0% and 83.3% of patients receiving 40, 80 and 120 mg of febuxostat, respectively, 58.3% of those receiving 300 mg of allopurinol and none of the placebo (p<0.001: each febuxostat dose or allopurinol group versus placebo group, p=0.0484 and p=0.0196: febuxostat 80 and 120 mg compared with allopurinol, respectively). The number and proportion of subjects who developed adverse events (AEs) were 13 subjects (37%), 14 (39%) and 18 (50%) in the febuxostat of 40, 80 and 120 mg group, respectively, 21 (57%) in the allopurinol 300 mg group and 17 (46%) in the placebo group. No statistically significant differences in the incidence rates of adverse events were observed between the groups. There was no significant difference in gout flare-up incidence. Conclusion. Febuxostat, 80 mg or 120 mg, was more effective than allopurinol (300 mg) or placebo, when lowering the serum urate. The safety of febuxostat and allopurinol was comparable.
Yun-Beom Sim,Soo-Hyun Park,Yu-Jung Kang,Sung-Su Kim,Chea-Ha Kim,Su-Jin Kim,Jun-Sub Jung,Ohk-Hyun Ryu,Moon-Gi Choi,Seong-Soo Choi,Hong-Won Suh 대한생리학회-대한약리학회 2013 The Korean Journal of Physiology & Pharmacology Vol.17 No.2
In the present study, the effect of intrathecal (i.t.) or intracerebroventricular (i.c.v.) administration with cholera toxin (CTX) on the blood glucose level was examined in ICR mice. The i.t. treatment with CTX alone for 24 h dose-dependently increased the blood glucose level. However, i.c.v. treatment with CTX for 24 h did not affect the blood glucose level. When mice were orally fed with D-glucose (2 g/kg), the blood glucose level reached to a maximum level at 30 min and almost returned to the control level at 120 min after D-glucose feeding. I.c.v. pretreatment with CTX increased the blood glucose level in a potentiative manner, whereas i.t. pretreatment with CTX increased the blood glucose level in an additive manner in a D-glucose fed group. In addition, the blood glucose level was increased in formalin-induced pain animal model. I.c.v. pretreatment with CTX enhanced the blood glucose level in a potentiative manner in formalin-induced pain animal model. On the other hand, i.t. pretreatment with CTX increased the blood glucose level in an additive manner in formalin-induced pain animal model. Our results suggest that CTX administered supraspinally or spinally differentially modulates the regulation of the blood glucose level in D-glucose fed model as well as in formalin-induced pain model.